Concepedia

Xuewu Liang

XL

Statistics

Publications

16

Citations

544

H-Index

12

Active since

2013

Affiliations

Shandong University(Current)

Chinese Academy of Sciences

Shanghai Institute of Materia Medica

Medical University of South Carolina

Georgia State University

Xuewu Liang is an author at Shandong University specializing in pharmacology, drug discovery, and medicinal chemistry.

ORCID

Publications per year

2013–2025

16

Publications

16

Discovery of Novel Pazopanib-Based HDAC and VEGFR Dual Inhibitors Targeting Cancer Epigenetics and Angiogenesis Simultaneously

Jie Zang, Xuewu Liang, Yongxue Huang et al. · Journal of Medicinal Chemistry · 2018 · 104 citations · Full text

, , +16

Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological Malignancies

Xuewu Liang, Jie Zang, Xiaoyang Li et al. · Journal of Medicinal Chemistry · 2019 · 85 citations · Full text

, , +16

Discovery of Novel Pyrrolo[2,3-<i>d</i>]pyrimidine-based Derivatives as Potent JAK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors

Xuewu Liang, Shuai Tang, Xuyi Liu et al. · Journal of Medicinal Chemistry · 2021 · 67 citations · Full text

, , +13

Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant

Vasanthanathan Poongavanam, Dongwei Kang, Chiara Bertagnin et al. · Journal of Medicinal Chemistry · 2018 · 57 citations · Full text

, , +17

Design, synthesis and anti-tumor activity study of novel histone deacetylase inhibitors containing isatin-based caps and o-phenylenediamine-based zinc binding groups

Jie Zang, Qianwen Gao, Xuewu Liang et al. · Bioorganic & Medicinal Chemistry · 2017 · 41 citations · Full text

, , +12

1–5 of 16